Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Angiozyme

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Serum and plasma levels of vascular endothelial growth factor (VEGF) correlate with prognosis in patients with metastatic breast… Expand
Highly Cited
2005
Highly Cited
2005
Purpose: This study intended to determine the maximum tolerated dose, safety, pharmacokinetic variables, clinical response, and… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
2004
2004
PurposeRPI.4610 (ANGIOZYME) is a chemically stabilized ribozyme targeting vascular endothelial growth factor receptor 1. The… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Review
2001
Review
2001
Several inhibitors of angiogenesis are being developed for the treatment of cancer. One dominant strategy involves disruption of… Expand
Review
2000
Review
2000
The discovery of ribozymes by Cech and Altman has fundamentally changed the view of the function of RNA in chemistry, biology… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
2000
2000
The potential acute toxicity of a ribozyme (ANGIOZYME) targeting the flt-1 vascular endothelial growth factor (VEGF) receptor… Expand
2000
2000
A significant amount of research has been devoted to the chemical stabilization of synthetic ribozymes, in part, so that… Expand
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • figure 5